UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES

Patent Applications and Registrations

Patent applications and USPTO patent grants for UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES.The latest application filed is for "methods and compositions for diagnosing depression".

Company Profile

0.12.9

UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES - Little Rock AZ US
University of Arkansas for Medical Sciences -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions For Diagnosing Depression App 20220187315 - Kaddurah-Daouk; Rima F. ; et al.	2022-06-16
Device And Method For In Vivo Detection Of Clots Within Circulatory Vessels App 20160354150 - Zharov; Vladimir Pavlovich ; et al.	2016-12-08
Use of statins in the prevention and treatment of radiation injury and other disorders associated with reduced endothelial thrombomodulin App 20100204254 - Hauer-Jensen; Martin K. ; et al.	2010-08-12
Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof Grant 7,638,277 - O'Brien , et al. December 29, 2	2009-12-29
Molecular determinants of myeloma bone disease and uses thereof Grant 7,459,437 - Shaughnessy December 2, 2	2008-12-02
Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme Grant 7,335,351 - O'Brien , et al. February 26, 2	2008-02-26
Method of inducing immunity against stratum corneum chymotrytic enzyme Grant 7,306,927 - O'Brien December 11, 2	2007-12-11
Diagnosis of multiple myeloma on gene expression profiling Grant 7,308,364 - Shaughnessy , et al. December 11, 2	2007-12-11
TADG-15: an extracellular serine protease overexpressed in carcinomas Grant 7,291,462 - O'Brien , et al. November 6, 2	2007-11-06
Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme Grant 7,282,198 - O'Brien , et al. October 16, 2	2007-10-16
Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs Grant 7,202,348 - Owens , et al. April 10, 2	2007-04-10
Uses of collagen IV Grant 7,183,383 - Schnellmann , et al. February 27, 2	2007-02-27
Extracellular serine protease Grant 7,067,250 - Underwood , et al. June 27, 2	2006-06-27
Extracellular serine protease App 20060068483 - Underwood; Lowell J. ; et al.	2006-03-30
Methods for the early diagnosis of ovarian cancer Grant 6,875,609 - O'Brien , et al. April 5, 2	2005-04-05
Derivatives of butyric acid and uses thereof App 20040127564 - Gilbert, Kathleen ; et al.	2004-07-01
Extracellular serine protease Grant 6,642,013 - O'Brien , et al. November 4, 2	2003-11-04
Tumor antigen-derived gene 16 (TADG-16): a novel extracellular serine protease and uses thereof App 20030027144 - Underwood, Lowell J. ; et al.	2003-02-06
Compositions and methods for the early diagnosis of ovarian cancer App 20020160365 - O' Brien, Timothy J.	2002-10-31
Compositions and methods for the early diagnosis of ovarian cancer App 20020146708 - O'Brien, Timothy I.	2002-10-10
Derivatives of butyric acid and uses thereof App 20020143056 - Gilbert, Kathleen ; et al.	2002-10-03

Company Registrations

CAGE Code

4RP76

UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES OFFICE OF CONTINUING MEDICAL EDUCATION

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.